Search results
Results from the WOW.Com Content Network
NVAX data by YCharts. Novavax's late-stage trials hit a snag. Novavax successfully developed a COVID-19 vaccine that is currently its only product on the market. The company has been working on ...
After Moderna’s development of a COVID-19 vaccine fueled a massive surge in revenue — rising more than 2,000% in 2021 from the prior year, with the vaccine maker turning its first-ever profit ...
Kennedy has long railed against vaccines, once calling those that protect against Covid-19 a "crime against humanity." He has treaded more carefully in recent weeks, though, and has said he wouldn ...
Shares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and 9.3%, respectively, through Thursday ...
Stocks of coronavirus vaccine could run out at the end of January unless new ones such as the Oxford jab are approved, a former minister has warned. Former health secretary Jeremy Hunt told the ...
A gauge of global stocks hit a record and oil prices jumped on Monday as the newest positive data for a potential COVID-19 vaccine and signs of economic recovery in Asia boosted sentiment. U.S ...
Stocks gained and bonds dropped on Wednesday as news of a working COVID-19 vaccine outweighed worries over surging infections, fuelling rotation towards cut-price losers from the coronavirus ...
(Reuters) -Pfizer set off a fresh round of concern about the size of the U.S. COVID-19 vaccine and treatment market in the long term, driving down shares on Monday of its German partner BioNTech ...